Drug discovery requires two separate steps: checking whether a drug can bind to a harmful molecule or its receptor, and ...

According to data published by Precedence Research, Generative AI is transforming the life science sector, driving innovation in drug discovery, clinical trials, and manufacturing, while reducing ...

Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

Explore AI in drug discovery and its journey from promise to proof in 2025 with significant achievements and challenges faced.

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

Protai, an AI drug discovery startup, announced its participation in a series of major scientific conferences this spring, where it will present significant advances in its AIMS™ proteomics-aware-AI ...

French preclinical CRO NovAliX has found a new partner across the pond. Massachusetts-based manufacturer Bruker Corporation has announced a minority investment in the CRO. “This partnership with ...

Overview AI is speeding up drug discovery by analyzing large biological and chemical data in a short time.Deep learning and ...

There’s no doubt that large language models and generative AI tools have taken the world by storm. Their ability to create, ...

Antimicrobial resistance (AMR) is diminishing the effectiveness of existing antibiotics and intensifying the need for discovery pipelines that are both ...

Figure 1. This figure depicts the four categories of protein druggability target screening tools discussed in this section, which include structure-based methods, sequence-based methods, machine ...